Eduction in ImmunoSuppressive Regimen Among Kidney Transplant Recipients Patients Admitted to the Intensive Care Unit for Septic Shock and/or Acute Respiratory Failure

NCT06881927 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

212

Enrollment

OTHER

Sponsor class

Conditions

Sepsis and Septic Shock
Acute Respiratory Failure
Kidney Transplant Recipients
Immunosuppressive Agents

Interventions

DRUG: Hydrocortisone Hemisuccinate: 200 mg per day.
OTHER: reduction of the level of immunosuppression

Sponsor

University Hospital, Strasbourg, France